ARMP vs CME · $70.2M cap vs P/E 22, rev $3.59B
Armata Pharmaceuticals Inc (ARMP) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Armata Pharmaceuticals Inc (ARMP) is a biotechnology company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
ARMP does not have a complete income-statement cache yet.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
ARMP currently screens at market cap $70.2M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the ARMP and CME stock pages for the full models.
Not investment advice.